Business
This is Koch Brothers first investment in Israel. InSightec engages in the development and production of medical therapeutic systems.
Hi, what are you looking for?
Jewish Business News
Business
Teva CEO warns that without an aggressive efficiency plan, "there will be no Teva," a move that can now be learned only how to...
Business
Atox Bio will use the funds to support Phase 2 study for Acute Kidney Injury; Phase 3 study of Reltecimod for Necrotizing Soft Tissue...
Business
The studies with novel drug Gammora yielded promising results with the malignant tumors in mice shrinking by 50% over a period of just two...
Business
selling Teva shares due to concerns over the performance of the generic drug division in the United States and the company's growing debt levels.
Business
Len Blavatnik's interests in Israel include control of Clal Industries,and indirect control of Channel 10 television, and a stake in Reshet Channel 13
Business
Two months after agreeing to buy Israeli company Kate Pharma for $11.9 billion cash, Pharma giant Gilead is making a breakthrough in the anti-cancer...
Business
New Teva CEO Kare Schultz will earn an annual salary of $2 million and a performance-dependent bonus of 140% - and up to a...
Life science
Kare Schultz brings Global Pharmaceutical experience, Including at Lundbeck and Novo Nordisk Proven Track Record of Implementing Turnaround Strategies
Business
BiondVax, the developer of the universal flu vaccine, progresses towards Phase 3 clinical trials and construction of its commercial manufacturing facility; The Company also...